Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Simultaneous Portal and Hepatic Vein Embolization Versus Portal Vein Embolization for Hypertrophy of the Future Liver Remnant Before Major Hepatectomy of Non-cirrhotic Liver : a Multicentric Comparative Randomized Phase II Trial

NCT03841305 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03841305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03841305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Simultaneous Portal and Hepatic Vein Embolization Versus Portal Vein Embolization for Hypertrophy of the Future Liver Remnant Before Major Hepatectomy of Non-cirrhotic Liver : a Multicentric Comparative Randomized Phase II Trial
Lead sponsor
University Hospital, Montpellier
Phase
Phase 2
Overall status
Completed
Start date
April 29, 2019
Completion date
October 10, 2024
Enrollment
64 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

liver metastasis colon cancer